We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Enteric-Coated Sodium Bicarbonate Attenuates Gastrointestinal Side-Effects.
- Authors
Hilton, Nathan Philip; Leach, Nicholas Keith; Craig, Melissa May; Sparks, S. Andy; McNaughton, Lars Robert
- Abstract
Enteric-formulated capsules can mitigate gastrointestinal (GI) side effects following sodium bicarbonate (NaHCO3) ingestion; however, it remains unclear how encapsulation alters postingestion symptoms and acid--base balance. The current study aimed to identify the optimal ingestion form to mitigate GI distress following NaHCO3 ingestion. Trained males (n = 14) ingested 300 mg/kg body mass of NaHCO3 in gelatin (GEL), delayed-release (DEL), and enteric-coated (ENT) capsules or a placebo in a randomized cross-over design. Blood bicarbonate anion concentration, potential hydrogen, and GI symptoms were measured pre- and postingestion for 3 hr. Fewer GI symptoms were reported with ENT NaHCO3 than with GEL (p = .012), but not with DEL (p = .106) in the postingestion phase. Symptom severity decreased with DEL (4.6 ± 2.8 arbitrary units) compared with GEL (7.0 ± 2.6 arbitrary units; p = .001) and was lower with ENT (2.8 ± 1.9 arbitrary units) compared with both GEL (p < .0005) and DEL (p = .044) NaHCO3. Blood bicarbonate anion concentration increased in all NaHCO3 conditions compared with the placebo (p < .0005), although this was lower with ENT than with GEL (p = .001) and DEL (p < .0005) NaHCO3. Changes in blood potential hydrogen were reduced with ENT compared with GEL (p = .047) and DEL (p = .047) NaHCO3, with no other differences between the conditions. Ingestion of ENT NaHCO3 attenuates GI disturbances for up to 3 hr postingestion. Therefore, ENT ingestion forms may be favorable for those who report GI disturbances with NaHCO3 supplementation or for those who have previously been deterred from its use altogether.
- Subjects
GASTROINTESTINAL disease diagnosis; GASTROINTESTINAL disease prevention; ACID-base equilibrium; BODY weight; PHARMACEUTICAL encapsulation; CONTROLLED release preparations; CROSSOVER trials; DIETARY supplements; GASTROINTESTINAL diseases; SODIUM bicarbonate; RANDOMIZED controlled trials; SEVERITY of illness index
- Publication
International Journal of Sport Nutrition & Exercise Metabolism, 2020, Vol 30, Issue 1, p62
- ISSN
1526-484X
- Publication type
Article
- DOI
10.1123/ijsnem.2019-0151